Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Kinase Chemodiversity from the Arctic: The Breitfussins.

Hansen KØ, Andersen JH, Bayer A, Pandey SK, Lorentzen M, Jørgensen KB, Sydnes MO, Guttormsen Y, Baumann M, Koch U, Klebl B, Eickhoff J, Haug BE, Isaksson J, Hansen EH.

J Med Chem. 2019 Nov 27;62(22):10167-10181. doi: 10.1021/acs.jmedchem.9b01006. Epub 2019 Nov 14.

PMID:
31647655
2.

Structural determinants and cellular environment define processed actin as the sole substrate of the N-terminal acetyltransferase NAA80.

Goris M, Magin RS, Foyn H, Myklebust LM, Varland S, Ree R, Drazic A, Bhambra P, Støve SI, Baumann M, Haug BE, Marmorstein R, Arnesen T.

Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):4405-4410. doi: 10.1073/pnas.1719251115. Epub 2018 Mar 26.

3.

Treatment of acute myocardial infarction in the sub-arctic region of Norway. Do we offer an equal quality of care?

Norum J, Hovland A, Balteskard L, Trovik T, Haug B, Hansen FH, Alterskjær S, Madsen P, Olsen F.

Int J Circumpolar Health. 2017;76(1):1391651. doi: 10.1080/22423982.2017.1391651.

4.

Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model.

Nestvold J, Wang MY, Camilio KA, Zinöcker S, Tjelle TE, Lindberg A, Haug BE, Kvalheim G, Sveinbjørnsson B, Rekdal Ø.

Oncoimmunology. 2017 Jun 16;6(8):e1338236. doi: 10.1080/2162402X.2017.1338236. eCollection 2017.

5.

LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment.

Sveinbjørnsson B, Camilio KA, Haug BE, Rekdal Ø.

Future Med Chem. 2017 Aug;9(12):1339-1344. doi: 10.4155/fmc-2017-0088. Epub 2017 May 11.

6.

Calculating the 30-day Survival Rate in Acute Myocardial Infarction: Should we Use the Treatment Chain or the Hospital Catchment Model?

Norum J, Hansen TM, Hovland A, Balteskard L, Haug B, Olsen F, Trovik T.

Heart Int. 2017 Feb 12;12(1). pii: heartint.5000238. doi: 10.5301/heartint.5000238. eCollection 2017 Jan-Dec.

7.

Influence of chain length on the activity of tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4).

Baumann M, Hussain MM, Henne N, Garrote DM, Karlshøj S, Fossen T, Rosenkilde MM, Våbenø J, Haug BE.

Bioorg Med Chem. 2017 Jan 15;25(2):646-657. doi: 10.1016/j.bmc.2016.11.036. Epub 2016 Nov 21.

PMID:
27939345
8.

[The future PCI treatment after heart attack].

Haug B, Rolstad OJ, Vegsundvåg J.

Tidsskr Nor Laegeforen. 2016 Oct 25;136(19):1612-1613. eCollection 2016 Oct. Norwegian. No abstract available.

9.

Crystal Structure of the Golgi-Associated Human Nα-Acetyltransferase 60 Reveals the Molecular Determinants for Substrate-Specific Acetylation.

Støve SI, Magin RS, Foyn H, Haug BE, Marmorstein R, Arnesen T.

Structure. 2016 Jul 6;24(7):1044-56. doi: 10.1016/j.str.2016.04.020. Epub 2016 Jun 16.

10.

Enrichment and identification of biosurfactant-producing oil field microbiota utilizing electron acceptors other than oxygen and nitrate.

Kryachko Y, Semler D, Vogrinetz J, Lemke M, Links MG, McCarthy EL, Haug B, Hemmingsen SM.

J Biotechnol. 2016 Aug 10;231:9-15. doi: 10.1016/j.jbiotec.2016.05.014. Epub 2016 May 19.

PMID:
27212608
11.

Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma.

Dyberg C, Papachristou P, Haug BH, Lagercrantz H, Kogner P, Ringstedt T, Wickström M, Johnsen JI.

BMC Cancer. 2016 Mar 31;16:259. doi: 10.1186/s12885-016-2293-2.

12.

Discovery of a 9-mer Cationic Peptide (LTX-315) as a Potential First in Class Oncolytic Peptide.

Haug BE, Camilio KA, Eliassen LT, Stensen W, Svendsen JS, Berg K, Mortensen B, Serin G, Mirjolet JF, Bichat F, Rekdal Ø.

J Med Chem. 2016 Apr 14;59(7):2918-27. doi: 10.1021/acs.jmedchem.5b02025. Epub 2016 Mar 29.

PMID:
26982623
13.

Discovery of a Specific Inhibitor of Pyomelanin Synthesis in Legionella pneumophila.

Aubi O, Flydal MI, Zheng H, Skjærven L, Rekand I, Leiros HK, Haug BE, Cianciotto NP, Martinez A, Underhaug J.

J Med Chem. 2015 Nov 12;58(21):8402-12. doi: 10.1021/acs.jmedchem.5b01589. Epub 2015 Oct 23.

PMID:
26458252
14.

Probing the Molecular Interactions between CXC Chemokine Receptor 4 (CXCR4) and an Arginine-Based Tripeptidomimetic Antagonist (KRH-1636).

Zachariassen ZG, Karlshøj S, Haug BE, Rosenkilde MM, Våbenø J.

J Med Chem. 2015 Oct 22;58(20):8141-53. doi: 10.1021/acs.jmedchem.5b00987. Epub 2015 Oct 2.

PMID:
26397724
15.

Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists.

Våbenø J, Haug BE, Rosenkilde MM.

Future Med Chem. 2015;7(10):1261-83. doi: 10.4155/fmc.15.64. Review.

PMID:
26144264
16.

Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs.

Haug BH, Hald ØH, Utnes P, Roth SA, Løkke C, Flægstad T, Einvik C.

Anticancer Res. 2015 May;35(5):2521-30.

PMID:
25964525
17.

A concise total synthesis of breitfussin A and B.

Pandey SK, Guttormsen Y, Haug BE, Hedberg C, Bayer A.

Org Lett. 2015 Jan 2;17(1):122-5. doi: 10.1021/ol503348n. Epub 2014 Dec 16.

PMID:
25514017
18.

Pseudoaeruginosins, nonribosomal peptides in Nodularia spumigena.

Liu L, Budnjo A, Jokela J, Haug BE, Fewer DP, Wahlsten M, Rouhiainen L, Permi P, Fossen T, Sivonen K.

ACS Chem Biol. 2015 Mar 20;10(3):725-33. doi: 10.1021/cb5004306. Epub 2014 Dec 5.

PMID:
25419633
19.

Reversible ketomethylene-based inhibitors of human neutrophil proteinase 3.

Budnjo A, Narawane S, Grauffel C, Schillinger AS, Fossen T, Reuter N, Haug BE.

J Med Chem. 2014 Nov 26;57(22):9396-408. doi: 10.1021/jm500782s. Epub 2014 Nov 12.

PMID:
25365140
20.

Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4).

Zachariassen ZG, Thiele S, Berg EA, Rasmussen P, Fossen T, Rosenkilde MM, Våbenø J, Haug BE.

Bioorg Med Chem. 2014 Sep 1;22(17):4759-69. doi: 10.1016/j.bmc.2014.07.004. Epub 2014 Jul 14.

PMID:
25082513
21.

Metabolic alkalosis is the most common acid-base disorder in ICU patients.

Mæhle K, Haug B, Flaatten H, Nielsen E.

Crit Care. 2014 Mar 28;18(2):420. doi: 10.1186/cc13802. No abstract available.

22.

In silico design, synthesis, and assays of specific substrates for proteinase 3: influence of fluorogenic and charged groups.

Narawane S, Budnjo A, Grauffel C, Haug BE, Reuter N.

J Med Chem. 2014 Feb 13;57(3):1111-5. doi: 10.1021/jm401559r. Epub 2014 Jan 21.

PMID:
24397704
23.

Nitroreductase, a near-infrared reporter platform for in vivo time-domain optical imaging of metastatic cancer.

McCormack E, Silden E, West RM, Pavlin T, Micklem DR, Lorens JB, Haug BE, Cooper ME, Gjertsen BT.

Cancer Res. 2013 Feb 15;73(4):1276-86. doi: 10.1158/0008-5472.CAN-12-2649. Epub 2012 Dec 10.

24.

Interaction of local anaesthetic articaine enantiomers with brain lipids: a Langmuir monolayer study.

Steinkopf S, Hanekam L, Schaathun M, Budnjo A, Haug BE, Nerdal W.

Eur J Pharm Sci. 2012 Sep 29;47(2):394-401. doi: 10.1016/j.ejps.2012.06.010. Epub 2012 Jun 27.

PMID:
22750081
25.

Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.

Rekdal Ø, Haug BE, Kalaaji M, Hunter HN, Lindin I, Israelsson I, Solstad T, Yang N, Brandl M, Mantzilas D, Vogel HJ.

J Biol Chem. 2012 Jan 2;287(1):233-44. doi: 10.1074/jbc.M111.279281. Epub 2011 Nov 4.

26.

Pacemaker implantation in small hospitals: complication rates comparable to larger centres.

Haug B, Kjelsberg K, Lappegård KT.

Europace. 2011 Nov;13(11):1580-6. doi: 10.1093/europace/eur162. Epub 2011 Jun 28. Review.

27.

Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.

Buechner J, Tømte E, Haug BH, Henriksen JR, Løkke C, Flægstad T, Einvik C.

Br J Cancer. 2011 Jul 12;105(2):296-303. doi: 10.1038/bjc.2011.220. Epub 2011 Jun 7.

28.

MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.

Haug BH, Henriksen JR, Buechner J, Geerts D, Tømte E, Kogner P, Martinsson T, Flægstad T, Sveinbjørnsson B, Einvik C.

Carcinogenesis. 2011 Jul;32(7):1005-12. doi: 10.1093/carcin/bgr073. Epub 2011 May 13.

PMID:
21572098
29.

Intramolecular hydrogen bonding in articaine can be related to superior bone tissue penetration: a molecular dynamics study.

Skjevik AA, Haug BE, Lygre H, Teigen K.

Biophys Chem. 2011 Feb;154(1):18-25. doi: 10.1016/j.bpc.2010.12.002. Epub 2010 Dec 16.

PMID:
21227568
30.

Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma.

Henriksen JR, Haug BH, Buechner J, Tømte E, Løkke C, Flaegstad T, Einvik C.

BMC Dev Biol. 2011 Jan 3;11:1. doi: 10.1186/1471-213X-11-1.

31.

Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.

Buechner J, Henriksen JR, Haug BH, Tømte E, Flaegstad T, Einvik C.

Differentiation. 2011 Jan;81(1):25-34. doi: 10.1016/j.diff.2010.09.184. Epub 2010 Oct 25.

PMID:
20980091
32.

[Reliability of air ambulances--a survey in three municipalities in Helgeland?].

Haug B, Avall A, Monsen SA.

Tidsskr Nor Laegeforen. 2009 May 28;129(11):1089-93. doi: 10.4045/tidsskr.08.0306. Norwegian.

33.

[Young woman in need of a pacemaker].

Haug B, Lappegård K.

Tidsskr Nor Laegeforen. 2008 Nov 6;128(21):2448-50. Norwegian. No abstract available.

PMID:
19105263
34.

[Placing pacemaker--no conclusive answer].

Haug B, Lappegård KT.

Tidsskr Nor Laegeforen. 2008 Nov 20;128(22):2619. Norwegian. No abstract available.

35.

Gene symbol: PROS1. Disease: Protein S deficiency.

Steidle M, Pfanner G, Haug B.

Hum Genet. 2008 Oct;124(3):316. No abstract available.

PMID:
18846666
36.

Gene symbol: PROS1. Disease: Protein S deficiency.

Steidle M, Pfanner G, Haug B.

Hum Genet. 2008 Oct;124(3):313. No abstract available.

PMID:
18846658
37.

Synthetic antimicrobial peptidomimetics with therapeutic potential.

Haug BE, Stensen W, Kalaaji M, Rekdal Ø, Svendsen JS.

J Med Chem. 2008 Jul 24;51(14):4306-14. doi: 10.1021/jm701600a. Epub 2008 Jun 21.

PMID:
18570363
38.

Antimicrobial peptides with stability toward tryptic degradation.

Svenson J, Stensen W, Brandsdal BO, Haug BE, Monrad J, Svendsen JS.

Biochemistry. 2008 Mar 25;47(12):3777-88. doi: 10.1021/bi7019904. Epub 2008 Feb 29.

PMID:
18307313
39.

Application of the Suzuki-Miyaura cross-coupling to increase antimicrobial potency generates promising novel antibacterials.

Haug BE, Stensen W, Svendsen JS.

Bioorg Med Chem Lett. 2007 Apr 15;17(8):2361-4. Epub 2006 Dec 21.

PMID:
17350833
40.

The medicinal chemistry of short lactoferricin-based antibacterial peptides.

Haug BE, Strøm MB, Svendsen JS.

Curr Med Chem. 2007;14(1):1-18. Review.

PMID:
17266565
41.

Temporal pattern of source activities evoked by different types of motion onset stimuli.

Delon-Martin C, Gobbelé R, Buchner H, Haug BA, Antal A, Darvas F, Paulus W.

Neuroimage. 2006 Jul 15;31(4):1567-79. Epub 2006 Mar 31.

PMID:
16580846
42.

Facile degradative lactonization of Gln-Arg and Gln-Phe hydroxyethylene dipeptide derivatives.

Haug BE, Brewer M, Rich DH.

J Pept Res. 2005 Jan;65(1):77-83.

PMID:
15759328
43.

Synthesis of a Gln-Phe hydroxy-ethylene dipeptide isostere.

Haug BE, Rich DH.

Org Lett. 2004 Dec 9;6(25):4783-6.

PMID:
15575685
44.

Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides.

Haug BE, Stensen W, Stiberg T, Svendsen JS.

J Med Chem. 2004 Aug 12;47(17):4159-62.

PMID:
15293987
45.
46.

Pacemaker implantation in patients with persistent left superior vena cava.

Lappegård KT, Prytz JF, Haug B.

Heart Vessels. 2004 May;19(3):153-4.

PMID:
15168065
47.

Axonal neuregulin-1 regulates myelin sheath thickness.

Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role L, Lai C, Schwab MH, Nave KA.

Science. 2004 Apr 30;304(5671):700-3. Epub 2004 Mar 25.

49.

Recent advances in clinical neurophysiology of vision.

Tobimatsu S, Celesia GG, Haug BA, Onofrj M, Sartucci F, Porciatti V.

Suppl Clin Neurophysiol. 2000;53:312-22. Review. No abstract available.

PMID:
12741013
50.

The pharmacophore of short cationic antibacterial peptides.

Strøm MB, Haug BE, Skar ML, Stensen W, Stiberg T, Svendsen JS.

J Med Chem. 2003 Apr 24;46(9):1567-70.

PMID:
12699374

Supplemental Content

Support Center